UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q2 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,485,248 | +34.0% | 177,391 | -1.0% | 0.00% | – |
Q2 2023 | $1,854,544 | +835.4% | 179,183 | +735.0% | 0.00% | – |
Q1 2023 | $198,272 | +2.4% | 21,458 | -1.7% | 0.00% | – |
Q4 2022 | $193,552 | +5.8% | 21,821 | -0.8% | 0.00% | – |
Q3 2022 | $183,000 | +6.4% | 21,998 | +4.8% | 0.00% | – |
Q2 2022 | $172,000 | -87.7% | 20,990 | -87.0% | 0.00% | – |
Q1 2022 | $1,401,000 | -13.0% | 160,880 | -5.0% | 0.00% | – |
Q4 2021 | $1,611,000 | -43.0% | 169,301 | +0.8% | 0.00% | -100.0% |
Q3 2021 | $2,826,000 | -6.4% | 168,024 | -14.9% | 0.00% | 0.0% |
Q2 2021 | $3,018,000 | -25.3% | 197,554 | -4.7% | 0.00% | 0.0% |
Q1 2021 | $4,039,000 | -6.4% | 207,296 | -13.4% | 0.00% | 0.0% |
Q4 2020 | $4,314,000 | -9.1% | 239,380 | -2.7% | 0.00% | 0.0% |
Q3 2020 | $4,745,000 | -8.1% | 245,963 | +24.4% | 0.00% | 0.0% |
Q2 2020 | $5,165,000 | +25.9% | 197,719 | -14.0% | 0.00% | 0.0% |
Q1 2020 | $4,104,000 | -46.0% | 230,027 | +1.0% | 0.00% | -50.0% |
Q4 2019 | $7,600,000 | +42.6% | 227,763 | +1.8% | 0.00% | +100.0% |
Q3 2019 | $5,331,000 | +168.2% | 223,707 | +304.3% | 0.00% | – |
Q2 2019 | $1,988,000 | +105.4% | 55,336 | +111.3% | 0.00% | – |
Q1 2019 | $968,000 | +27.7% | 26,194 | +48.8% | 0.00% | – |
Q4 2018 | $758,000 | +0.3% | 17,598 | +10.0% | 0.00% | – |
Q3 2018 | $756,000 | +11.7% | 15,998 | +17.6% | 0.00% | – |
Q2 2018 | $677,000 | – | 13,598 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |